CLINICAL_TRIALS trial_result · 2021-04-06

Clinical Trial Update: Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis [NA]

Open-label extension of a dose-finding study in Juvenile Idiopathic Arthritis has been terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Italfarmaco | Conditions: Juvenile Idiopathic Arthritis | NA | Status: TERMINATED | Results posted: 2021-04-06